https://www.pharmaceutical-technology.com/news/a-tough-puzzle-complexity-slows-drug-development-for-concussions/
Last month saw two companies announce positive results from early-stage studies endeavoring to find a treatment for concussions, an area with no approved therapies.   On August 3, Oxeia Biopharma
Create an account or login to join the discussion